Trademark: 97020234
Word
NEUVIVO
Status Date
Wednesday, March 13, 2024
Filing Date
Thursday, September 9, 2021
Published for Opposition
Tuesday, July 19, 2022
5 medicines and pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (als); medicines and pharmaceutical preparations for the treatment of neurodegenerative diseases; medicines and pharmaceutical preparations for the treatment of central nervous system and peripheral nervous system diseases and disorders; medicines and pharmaceutical preparations for the treatment of viral diseases
42 scientific research for medical purposes in the field of amyotrophic lateral sclerosis (als), neurodegenerative diseases, central nervous system and peripheral nervous system diseases and disorders, and viral diseases
The mark consists of the word NEUVIVO in stylized lettering, with the letters NEU in bold, a bar through the center of the N and E, and VIVO in narrower lettering.
Mar 14, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 13, 2024
Sou Extension 3 Granted
Mar 13, 2024
Sou Extension 3 Filed
Mar 13, 2024
Sou Teas Extension Received
Sep 12, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 8, 2023
Sou Extension 2 Granted
Sep 8, 2023
Sou Extension 2 Filed
Sep 8, 2023
Sou Teas Extension Received
Mar 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 10, 2023
Sou Extension 1 Granted
Mar 10, 2023
Sou Extension 1 Filed
Mar 10, 2023
Sou Teas Extension Received
Dec 2, 2022
Assigned To Examiner
Sep 13, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 19, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 19, 2022
Published For Opposition
Jun 29, 2022
Notification Of Notice Of Publication E-Mailed
Jun 13, 2022
Approved For Pub - Principal Register
Jun 13, 2022
Assigned To Examiner
Oct 20, 2021
Notice Of Design Search Code E-Mailed
Oct 19, 2021
New Application Office Supplied Data Entered
Sep 13, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
